Opportunity Fund L.p. Samsara, 10% Owner at Kalaris Therapeutics, Inc. (KLRS), bought 479,847 shares at $10.42 ($5.0M) on 2025-12-18, disclosed to the SEC on 2026-02-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.